Novartis India's open offer has seen no participation from public shareholders as of June 15, 2026. The offer to acquire up to 26% of the company's voting share capital remains open, with Axis Capital managing the process.

Novartis India Open Offer Sees No Public Shareholder Tenders

As of June 15, 2026, no public shareholders have participated in the ongoing open offer for Novartis India Ltd. The offer aims to acquire up to 6,419,608 equity shares, representing 26% of the company's voting share capital.

Reader Takeaway: Zero tenders show initial shareholder hesitancy; offer completion hinges on future participation and verification.

What just happened

Novartis India Ltd has announced a procedural update regarding its ongoing open offer. As of June 15, 2026, the number of equity shares tendered by public shareholders in response to the offer is nil. This applies to shares submitted in both dematerialized and physical forms.

Why this matters

This update is crucial for investors monitoring the potential change in shareholding for Novartis India. The lack of initial tenders indicates that public shareholders are either waiting for more information, seeking better terms, or are not interested in selling at the current offer price. The offer's success hinges on eventual public participation.

The backstory

The open offer is being managed by Axis Capital Limited. The acquirer group includes WaveRise Investments Limited, ChrysCapital Fund X, and Two Infinity Partners, acting in concert with ChrysCapital X, LLC and OceanEdge Investments Limited. The Letter of Offer was dated June 1, 2026.

What changes now

Currently, nothing has materially changed from an acceptance standpoint. The open offer period is still active, and any shares tendered are subject to verification and validation processes. The final acceptance of shares will depend on the number of 'validly tendered' shares meeting SEBI (SAST) Regulations criteria.

Risks to watch

The primary risk is the continued lack of tender from public shareholders, which could lead to the offer not achieving its intended acquisition threshold. The verification process itself can also lead to a reduction in initially submitted tenders.

Peer comparison

Typically, open offers see varied participation rates depending on offer price, market conditions, and investor sentiment towards the target company. A zero-tender status at this stage is unusual and warrants close observation.

Context metrics (time-bound)

• Open Offer Period: Ongoing as of June 15, 2026.
• Shares to be acquired: Up to 6,419,608 equity shares (26% of voting share capital).
• Tender Status (as of June 15, 2026): Nil.
• Letter of Offer Date: June 1, 2026.

What to track next

Investors should closely monitor future updates on the tender status, especially as the offer period nears its end. Any significant increase in tendered shares or further announcements from the acquirer group or the company will be key developments.